These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21045640)

  • 1. The economic burden of dry eye disease in the United States: a decision tree analysis.
    Yu J; Asche CV; Fairchild CJ
    Cornea; 2011 Apr; 30(4):379-87. PubMed ID: 21045640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. United States cost-effectiveness study of two dry eye ophthalmic lubricants.
    Wlodarczyk J; Fairchild C
    Ophthalmic Epidemiol; 2009; 16(1):22-30. PubMed ID: 19191178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, burden, and pharmacoeconomics of dry eye disease.
    Pflugfelder SC
    Am J Manag Care; 2008 Apr; 14(3 Suppl):S102-6. PubMed ID: 18452369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
    Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
    Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
    Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic pregnancy in the United States: economic consequences and payment source trends.
    Washington AE; Katz P
    Obstet Gynecol; 1993 Feb; 81(2):287-92. PubMed ID: 8423966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs of anxiety disorders.
    DuPont RL; Rice DP; Miller LS; Shiraki SS; Rowland CR; Harwood HJ
    Anxiety; 1996; 2(4):167-72. PubMed ID: 9160618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists.
    Clegg JP; Guest JF; Lehman A; Smith AF
    Ophthalmic Epidemiol; 2006 Aug; 13(4):263-74. PubMed ID: 16877285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimates of the economic costs of birth defects.
    Waitzman NJ; Romano PS; Scheffler RM
    Inquiry; 1994; 31(2):188-205. PubMed ID: 8021024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
    Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
    J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The societal burden of osteoporosis in Sweden.
    Borgström F; Sobocki P; Ström O; Jönsson B
    Bone; 2007 Jun; 40(6):1602-9. PubMed ID: 17433804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic burden of pneumococcal disease in older US adults.
    Weycker D; Strutton D; Edelsberg J; Sato R; Jackson LA
    Vaccine; 2010 Jul; 28(31):4955-60. PubMed ID: 20576535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
    Sasser AC; Rousculp MD; Birnbaum HG; Oster EF; Lufkin E; Mallet D
    Womens Health Issues; 2005; 15(3):97-108. PubMed ID: 15894195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations in the pharmacoeconomics of dry eye.
    Hirsch JD
    Manag Care; 2003 Dec; 12(12 Suppl):33-8. PubMed ID: 14723112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of illness of hypertension among women using menopausal hormone therapy: a US perspective.
    Hawkins K; Mittapally R; Chang J; Nahum GG; Gricar J
    Curr Med Res Opin; 2010 Dec; 26(12):2823-32. PubMed ID: 21058896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.